During the structural analysis of recombinant protein biopharmaceutical products, a significant challenge is posed by the issue of Post Translational Modifications (PTMs). This is a very large area of investigation due to the number of PTMs that have been identified through the study of protein structures over the course of many years. Dr. Richard L. Easton at BioPharmaSpec explores more about the challenges of Post Translational Modifications.